Purica Pharmaceuticals Private Limited
Pharmaceutical company that deals with drugs, intermediates, and medical equipment.
2022 | Ahmedabad, Gujarat (India) | Active
Purica Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.50 Cr
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.69 Cr
- Revenue Growth %
- Net Worth 23055.23%
- Total Assets 358.44%
About Purica Pharmaceuticals
Purica Pharmaceuticals Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 July 2022 (Two years and ten months 18 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹4.69 Cr.
Tejas Raval, Shreel Raval, and Avi Raval serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290GJ2022PTC133682
- Company No.
133682
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
Purica Pharmaceuticals Private Limited
Explore comprehensive data for Purica Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Purica Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tejas Raval  | Director | 08-Jul-2022 | Current |
| Shreel Raval | Director | 08-Jul-2022 | Current |
| Avi Raval | Additional Director | 10-Feb-2025 | Current |
Financial Performance of Purica Pharmaceuticals.
Purica Pharmaceuticals Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 23055.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Purica Pharmaceuticals?
Unlock access to Purica Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Purica Healthcare LimitedTejas Raval and Shreel Raval are mutual person
- Srans Lifecare Private Limited
Tejas Raval and Shreel Raval are mutual person
- Tejas Holdings Private Limited
Tejas Raval and Shreel Raval are mutual person
Charges (Loans)
Open Charges
₹4.69 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 4.69 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 2023 | Idbi Bank Limited | ₹4.69 Cr | Open |
How Many Employees Work at Purica Pharmaceuticals?
Purica Pharmaceuticals has a workforce of 0 employees as of Mar 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Purica Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purica Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Purica Pharmaceuticals
Recent activity within the organization
- Director Appointment
Avi Tejas Raval was appointed as a Additional Director was appointed as a Additional Director on 10 Feb 2025 & has been associated with this company since 3 months 14 days .
- Annual General Meeting
Purica Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Purica Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
- Charges
A charge with Idbi Bank Limited amounted to Rs. 4.69 Cr with Charge ID 100725745 was registered on 12 Apr 2023.
- Director Appointment
Tejas Amrutlal Raval was appointed as a Director was appointed as a Director on 08 Jul 2022 & has been associated with this company since 2 years 10 months .
- Director Appointment
Shreel Raval was appointed as a Director was appointed as a Director on 08 Jul 2022 & has been associated with this company since 2 years 10 months .
Frequently asked questions
What is the Incorporation or founding date of Purica Pharmaceuticals Private Limited?
Purica Pharmaceuticals Private Limited was incorporated on 08 Jul 2022.
What is authorized share capital and paid-up capital of Purica Pharmaceuticals Private Limited?
The authorized share capital of Purica Pharmaceuticals Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 2.50 Cr.
Who are the current board members & directors of Purica Pharmaceuticals Private Limited?
Currently 3 directors are associated with Purica Pharmaceuticals Private Limited.
- Tejas Amrutlal Raval
- Shreel Raval
- Avi Tejas Raval
What is the registered address of Purica Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Purica Pharmaceuticals Private Limited is Bl No. 11/123, Parishram Appartment Nr Jai Shefali Row House Satellite India, Ahmedabad, Gujarat, 380015.
What is the corporate identification number (CIN) and company number of Purica Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Purica Pharmaceuticals Private Limited is U24290GJ2022PTC133682 and the company number is 133682 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Purica Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Purica Pharmaceuticals Private Limited has experienced an upsurge of 23055.23%.
What are the total open charges for Purica Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Purica Pharmaceuticals Private Limited amount to ₹ 4.69 Cr.
When was the last Balance Sheet of Purica Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Purica Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records